These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population. Zhao XL, Hu SY, Zhang Q, Dong L, Feng RM, Han R, Zhao FH. J Gynecol Oncol; 2017 Jul; 28(4):e30. PubMed ID: 28541628 [Abstract] [Full Text] [Related]
23. Cervical Microbiota Associated with Higher Grade Cervical Intraepithelial Neoplasia in Women Infected with High-Risk Human Papillomaviruses. Piyathilake CJ, Ollberding NJ, Kumar R, Macaluso M, Alvarez RD, Morrow CD. Cancer Prev Res (Phila); 2016 May; 9(5):357-66. PubMed ID: 26935422 [Abstract] [Full Text] [Related]
24. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study. Castle PE, Stoler MH, Wright TC, Sharma A, Wright TL, Behrens CM. Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084 [Abstract] [Full Text] [Related]
26. Clinical validation of the Cervista HPV HR and 16/18 genotyping tests for use in women with ASC-US cytology. Einstein MH, Martens MG, Garcia FA, Ferris DG, Mitchell AL, Day SP, Olson MC. Gynecol Oncol; 2010 Aug 01; 118(2):116-22. PubMed ID: 20488510 [Abstract] [Full Text] [Related]
30. Cervical intraepithelial neoplasia disease progression is associated with increased vaginal microbiome diversity. Mitra A, MacIntyre DA, Lee YS, Smith A, Marchesi JR, Lehne B, Bhatia R, Lyons D, Paraskevaidis E, Li JV, Holmes E, Nicholson JK, Bennett PR, Kyrgiou M. Sci Rep; 2015 Nov 17; 5():16865. PubMed ID: 26574055 [Abstract] [Full Text] [Related]
31. Human papillomavirus (HPV) E6/E7 mRNA as a triage test after detection of HPV 16 and HPV 18 DNA. Perez Castro S, Iñarrea Fernández A, Lamas González MJ, Sarán Diez MT, Cid Lama A, Alvarez Martín MJ, Pato Mosquera M, López-Miragaya I, Estévez N, Torres Piñón J, Oña Navarro M. J Med Virol; 2013 Jun 17; 85(6):1063-8. PubMed ID: 23588733 [Abstract] [Full Text] [Related]
34. Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada. Coutlée F, Ratnam S, Ramanakumar AV, Insinga RR, Bentley J, Escott N, Ghatage P, Koushik A, Ferenczy A, Franco EL. J Med Virol; 2011 Jun 17; 83(6):1034-41. PubMed ID: 21503917 [Abstract] [Full Text] [Related]
35. High-risk HPV genotypes in Zimbabwean women with cervical cancer: Comparative analyses between HIV-negative and HIV-positive women. Kuguyo O, Dube Mandishora RS, Thomford NE, Makunike-Mutasa R, Nhachi CFB, Matimba A, Dandara C. PLoS One; 2021 Jun 17; 16(9):e0257324. PubMed ID: 34582476 [Abstract] [Full Text] [Related]
36. The direct and indirect association of cervical microbiota with the risk of cervical intraepithelial neoplasia. Zhang C, Liu Y, Gao W, Pan Y, Gao Y, Shen J, Xiong H. Cancer Med; 2018 May 17; 7(5):2172-2179. PubMed ID: 29608253 [Abstract] [Full Text] [Related]
37. Frequent high-risk HPV co-infections excluding types 16 or 18 in cervical neoplasia in Guadeloupe. Gaete S, Auguste A, Bhakkan B, Peruvien J, Herrmann-Storck C, Socrier Y, Diedhiou A, Deloumeaux J. BMC Cancer; 2021 Mar 16; 21(1):281. PubMed ID: 33726684 [Abstract] [Full Text] [Related]